Wilmot Cancer Institute to celebrate cancer survivorship at fourth annual Wilmot Warrior Walk

More than 730 people expected on Sunday, Sept. 11

Friday, September 09, 2016


UR Medicine’s Wilmot Cancer Institute will host its fourth annual Wilmot Warrior Walk to celebrate life beyond cancer on Sunday, Sept. 11 at the Highland Park Bowl in Rochester. The event features a certified 5K, certified 10K and a 1-mile walk. Proceeds will support cancer research at Wilmot as well as the Judy DiMarzo Cancer Survivorship Program, established in 2012 to help cancer survivors navigate life after treatment.

More than 730 people are expected to attend this year’s event, which has already raised more than $55,000 through online donations. Since the first Wilmot Warrior Walk in 2013, the walk has raised more than $140,000 to support the survivorship program. This is the first year the event also benefits cancer research.

“More advances in cancer treatment make it possible to have more cancer survivors. Today, there are over 15 million cancer survivors living in the U.S. As research continues to make improvements, more people will live longer after a cancer diagnosis, but they will face new challenges adjusting to life after treatment,” says Jonathan W. Friedberg, M.D., M.M.Sc., director of Wilmot Cancer Institute. “The Wilmot Warrior Walk is important because, beyond a fantastic celebration, it provides funding for resources survivors need and helps fund cancer research happening right in our community. We’re so grateful for the generosity Rochester continues to show in the local fight against cancer by participating in events like this.”

Following the races, a celebration of cancer survivorship will start at 10:30 a.m. Scott Spezzano from 98.9 the Buzz will serve as emcee and the No Name Band will play live music. Young participants can enjoy bounce houses, and food trucks will be on site to sell food. Community groups will have booths to share information about healthy living and cancer survivorship. Participants can also try yoga or tai chi and learn from an exercise physiologist from URMC’s PEAK Lab. Because it is the 15th anniversary of the Sept. 11 attacks, a moment of remembrance will take place and firefighters from Rochester Fire Department Truck 3 plan to attend with a fire truck.

During a ceremony starting at 11:45 a.m., 29 cancer survivors and caregivers will be recognized as honorees for the way they’ve approached life when dealing with a cancer diagnosis. This year’s honorees are:

  • John Aarne, rectal cancer survivor from Macedon, and Valerie Aarne, his daughter and caregiver
  • Kailee McManus, tongue cancer survivor from Avon
  • Paul Barden, rectal cancer survivor from Fairport
  • Meghan Bauer, acute lymphoblastic lymphoma survivor from Greece
  • Jason Buitrago, testicular cancer survivor from Rochester, and Christopher Buitrago, Jason’s husband and caregiver
  • Jimmy Catalano, diagnosed with bladder cancer and passed away in 2016
  • Walter Chatman, Hodgkin’s lymphoma survivor from Rochester
  • Frank Colasurdo, lung cancer survivor from Newark
  • Mike Crumb, pancreatic cancer survivor from Hilton
  • Charleen Davis, breast cancer survivor from Orlando, Florida
  • Dennis DeVelder, brain cancer survivor from Gates
  • Jessica Drexler, colon cancer survivor from Gates
  • Eugene Evanitsky, brain cancer survivor from Pittsford
  • James Garrity, prostate cancer and lymphoma survivor from Irondequoit
  • Mary Georger, caregiver from West Irondequoit
  • Lorraine Griggs, caregiver from Webster
  • Matthew Hazzard, lymphoma survivor from Cooperstown
  • Paris Lanning, caregiver from Greece
  • Robert Larter, non-Hodgkins lymphoma survivor from Rochester
  • Denise Lazore, from Brockport, survivor of cervical cancer, breast cancer, multiple myeloma and lung cancer
  • Olivia Marsh, Ewing’s sarcoma survivor from Brighton
  • Steven Pelino, brain cancer survivor from Penfield
  • Kevin Rhode, esophageal cancer survivor from Penfield
  • Walt Standhart, pancreatic cancer survivor from Greece
  • Jacqueline Vaccaro, lacrimal sac (sinus) cancer survivor from Greece
  • Willard “Jim” Walker, larynx cancer survivor from Greece
  • Jim Walsh, colorectal cancer survivor from Pittsford

“These honorees personify what the Wilmot Warrior Walk is all about – celebrating the positives of life despite the tragedy and challenges that a cancer diagnosis often brings,” says Tiffany Paine-Cirrincione, associate director, Advancement and Community Events for Wilmot Cancer Institute. “We are delighted to lift up these 29 individuals and all who have been touched by cancer at the Wilmot Warrior Walk on Sunday.”

The Wilmot Warrior Walk is sponsored by Christian Flooring, Karl and Debbie Klein, Wegmans, Shadow Lake Golf Club, Texas de Brazil, Dunkin Donuts, Morgan Stanley, Richard DiMarzo, Dixon Schwabl, e-Health Technologies, Erdman Anthony and Manning & Napier.

Registration for the Wilmot Warrior Walk is $25. Participants can register online through Friday, Sept. 9 at 5 p.m. or they can register the day of the event, beginning at 7:30 a.m. To learn more or register, visit WarriorWalk.URMC.edu.


UR Medicine’s Wilmot Cancer Institute is the Finger Lakes region’s leader for cancer care and research. As a component of Strong Memorial Hospital, Wilmot Cancer Institute provides specialty cancer care services at the University of Rochester Medical Center and a network of locations throughout the region. The Institute also includes a team of 100 scientists who investigate many aspects of cancer, with an emphasis on how best to provide precision cancer care. To learn more, visit wilmot.urmc.edu.

Article Source

New Solid Organ Transplant Chief Joins UR Medicine’s Department of Surgery

Roberto Hernandez-Alejandro is a pioneer of innovative ALPPS procedure

Tuesday, September 13, 2016


The University of Rochester Medical Center has appointed Roberto Hernandez-Alejandro as chief of UR Medicine’s Division of Solid Organ Transplantation in the Department of Surgery.

Hernandez-Alejandro is an expert in transplantation, with a special interest in caring for patients who have been diagnosed with advanced liver cancer. He is one of the world’s foremost authorities on an innovative procedure called ALPPS, a two-step surgical technique that separates cancerous liver tissue from healthy tissue and promotes the rapid growth of the latter. The surgery is extending lives and improving quality of life, expanding the number of patients undergoing major liver resections that were not previously considered because of risk. He was the first in North America to perform the procedure and is still one of only a handful of surgeons in the world who possesses the expertise.

“We are extremely pleased to welcome Dr. Hernandez-Alejandro and his family to our community,” said Department of Surgery Chair David C. Linehan, M.D., the Seymour I. Schwartz Professor in Surgeryat the University of Rochester School of Medicine and Dentistry. “His unique expertise in transplantation and hepatobiliary surgery will bring added value to an already strong program. He is a gifted and innovative surgeon known nationally and internationally for his excellent results, his academic productivity and his leadership skills.”

Most recently an associate professor at Western University in Ontario, Canada, outside of Toronto, Hernandez-Alejandro served as director of Liver Transplantation and Hepatobiliary Surgery at London Health Sciences Centre – University Hospital.

Hernandez-Alejandro grew up in Mexico City, in a family he says stressed hard work and dedication and supported his interest in medicine at a young age. He was self-driven to understand the human body and, ultimately, to work as a surgeon to help patients survive injury and disease, first in general surgery and then following a strong calling as a transplant surgeon.

Hernandez-Alejandro graduated with honors from Universidad La Salle in Mexico City, followed by general surgery training at the Instituto Mexicano del Seguro Social, Centro Medico Siglo XXI. He completed a fellowship in transplantation for kidney and pancreas at the University of Calgary, with a second fellowship in liver transplantation and hepato-pancreato-biliary (HPB) surgery at Western University in London, Ontario. He received further training in living-donor liver transplantation and HPB at the University of Toronto and Kyoto University in Japan.

“I was drawn to URMC and UR Medicine because of the culture and passion for excellent patient care, research and education,” Hernandez-Alejandro said. “I am excited to build upon such a well-known, nationally respected transplant program, to further strengthen what transplant leadership before me has worked so hard to create – a comprehensive team that is laser-focused on providing the best medical opportunities for patients from throughout Upstate New York.”

Hernandez-Alejandro’s clinical interests include liver regeneration, colorectal liver metastases, donation after cardiac death and living-donor liver transplantation. His research endeavors are primarily focused on liver regeneration and ischemia reperfusion injury.

In the last five years he has published more than 30 peer-reviewed articles in journals such as the International Journal of Surgery, Annals of Surgery, Surgery, and World Journal of Surgery, as well as book chapters on the subjects of liver transplant techniques and liver resections. Hernandez-Alejandro has served over the past five years as an associate and section editor for TransplantNow, the Canadian Society of Transplantation’s online journal, and has been a journal reviewer for the Annals of Surgery, Surgery, British Journal of Surgery,and HPB, the journal of the International Hepato-Pancreato-Biliary Association.

He has been honored with numerous research and teaching awards, including twice receiving the Rising Star Award from the International Liver Transplantation Society, and was named a Researcher of the Month by Canadians for Health Research.

Hernandez-Alejandro succeeds transplant surgeon Mark S. Orloff, M.D., who was appointed as vice chair for Clinical Operations and Regional Development, a position that will focus on UR Medicine’s Western New York partners and their surgical programs. Orloff continues as a member of the Solid Organ Transplant surgical team.

Hernandez-Alejandro resides in Pittsford with his wife and three children.

Article Source

UR Medicine Cardiac Surgeons Perform 200th Heart Transplant

Oswego County mechanic gets 2nd chance at life thanks to generous organ donor

Tuesday, September 20, 2016


Stephen Waite Jr. and his wife, Christine, celebrate their 25th anniversary Sept. 21 and see a bright future after he received a heart transplant.

Cardiac surgeons at UR Medicine’s Strong Memorial Hospital recently performed a 200th heart transplant surgery, providing a 48-year-old father a second chance on life.

Transplant surgeons Juan Lehoux, M.D., surgical director of the Program in Heart Failure and Transplantation, and Sunil Prasad, M.D., performed the six-hour life-saving procedure Aug. 24 and Stephen Waite Jr. of Oswego is recovering at Strong Memorial Hospital.

Reaching this milestone is a proud moment for the heart failure and transplant team, an integral part of UR Medicine Heart & Vascular, which has more than 900 people dedicated to patient care and heart research.

Juan Lehoux, M.D.

“Every transplant provides a new beginning for our patients and is an incredible achievement for the entire team of doctors, nurses and support staff,” said Prasad, chief of Cardiac Surgery.

This milestone was 15 years in the making, as the team performed its first transplant Feb. 7, 2001. Strong Memorial is the only comprehensive heart failure and transplant center in upstate New York, serving the vast majority of the state: from Northern New York to the Pennsylvania state line.

“We work closely with patients and their families every day, and when a moment like this occurs, it reminds us how many lives we’ve helped change,” said Leway Chen, M.D., M.P.H. He has been director of the Program in Heart Failure and Transplantation since its inception. “When our transplant recipients share news of family weddings and share photos of grandchildren or trips to wonderful places, it brings a sense of pride and joy to have helped make it possible.”

Sunil Prasad, M.D.

For better or for worse

“I feel like a new man today,” said Waite. He and his wife, Christine, are “so grateful, because it’s been a long and tough road getting here.”

It’s especially poignant because they will celebrate their 25th anniversary on Sept. 21, having endured sickness and health.

Leway Chen, M.D., M.P.H.

Waite was 40 when he was diagnosed with non-ischemic cardiomyopathy and he “went from having a normal life to suddenly struggling with heart failure,” said his cardiologist Michael Fischi, M.D. F.A.C.C. F.S.C.A.I., of St. Joseph’s Physicians Cardiovascular Specialists in Syracuse.

UR Medicine cardiologists collaborated with Fischi to manage Waite’s care for several years. When the Oswego man didn’t recover as well as expected after mitral valve repair, Fischi referred him “to Strong Memorial Hospital, because I’m familiar with the physicians there. It’s an excellent program. When I send patients there, I know they’ll get great care.”

UR Medicine’s Cardiac Critical Care Transport Team – a specialized team operating in a dedicated ambulance – brought Waite to Rochester and cardiac surgeons implanted a left ventricular assist device (LVAD) to stabilize his heart function. For several years, transplant cardiologist Eugene Storozynsky, M.D., Ph.D., closely monitored his health and managed difficulties with the LVAD.

Eugene Storozynsky, M.D., Ph.D.

Nearly a month ago, Waite was briefly hospitalized at Strong Memorial, never realizing that his stay would be extended because the matching donor heart finally became available.

“It was late at night when doctors told me they had a good heart for me,” said the father of two young men. “It was exciting to know I will get a second chance.”

Today, he is eager to return to his Oswego home to “sleep in my own bed and get back to normal.”

His recovery and strides toward good health are satisfying for the entire heart transplant team. “We are always pleased to see patients like Mr. Waite do well after transplantation,” said Lehoux, transplant surgeon. “We are optimistic for Mr. Waite and expect to see continued progress.”

Pass Life On

Christine Waite, a nurse, is grateful to the heart donor whose generosity helped save her husband’s life.

“I look at Stephen and know that he is well today because a stranger was kind enough to donate a heart,” she said. “What was the best day for us was a terrible day for that person’s family and we will think of them always.”

Organ transplantation surgery is not possible without the generosity of donors. The number of people who need organ transplants far exceeds the number of organs donated each year. There are nearly 10,000 people in New York who need an organ transplant, according to the Finger Lakes Donor Recovery Network, the organ procurement organization affiliated with the University of Rochester Medical Center, in partnership with other Upstate New York hospitals. About 450 people are on Strong Memorial Hospital heart, liver, kidney or pancreas transplant program waiting lists.

New York state has a severe shortage of organ donors in its registry. Only about 27 percent of eligible people have registered to be an organ donor, which is less than half of the national average of 52 percent. In the Finger Lakes region, 34 percent of eligible adults are in the registry.

Low participation in organ donation means patients have to wait far longer for life-saving surgeries. Each day, 18 people in the United States die waiting for transplant surgery. In August, the state legislature approved lowering the age to join the registry from 18 to 16 starting in February.

There are 28 patients on the Strong Memorial heart transplant waiting list. They could wait as little as a few months to more than a year for a match.

Comprehensive care

UR Medicine teams partner with Harbor House for housing of family members of patients undergoing organ transplantation or critical care. The nearby home-away-from-home offers additional comfort and support for family members like Christine Waite, who stayed there while her husband recovered.

“It was a godsend to be so close to the hospital and have a wonderful place to stay when I needed to rest,” his wife said.

The Program in Heart Failure and Transplantation provides comprehensive care, using pharmacologic and high-tech devices to manage heart failure in addition to transplant surgery.

UR Medicine is a national leader in the use of ventricular assist devices (VAD) as a therapy for heart failure. VADs are implantable pumps that supplement or replace a patient’s heart function to keep them alive and as healthy as possible while they wait for a new heart. They also are used as long-term therapy for patients who are not eligible for transplant.

In 2012, UR Medicine cardiologists introduced the total artificial heart, a bridge-to-transplant device for patients with end-stage biventricular heart failure, a condition in which both sides of the heart become weakened and cannot pump blood adequately throughout the body.

The Heart & Vascular program also offers a Cardiac Critical Care Transport Team composed of cardiac critical care nurses, respiratory therapists, perfusionists and physicians. The team uses a vehicle equipped with leading-edge technology to assist patients being rushed from outlying areas to the Medical Center for expert care.

Article Source

URMC begins 7-year, $18M study of prenatal inflammation and child health

Wednesday, September 21, 2016


Over the past several decades, researchers have shown that an array of conditions in pregnant women, such as anxiety, stress, and obesity, are associated with a large and common cluster of behavioral and physical health conditions in the child. Now, researchers at the University of Rochester Medical Center (URMC) are embarking on a seven-year mission to study one factor that may explain the link: prenatal inflammation.

The research, supported by a grant from the National Institutes of Health that could total more than $18 million, is the first detailed longitudinal investigation of how inflammation — part of the body’s immune response — during pregnancy can affect a child’s neurodevelopment as well as the metabolic systems for processing nutrients and energy. Should the study reach its seven-year maturity, it will be one of the largest grants in URMC history.

“Obesity, stress, anxiety, and a history of trauma have all been linked with elevated levels of pro-inflammatory cytokines, which are chemicals that are part of the body’s immune response. This seems to be generally the case in adults and, of particular concern to us, in pregnant women,” said Thomas O’Connor, Ph.D., Professor of Psychiatry and Director of the Wynne Center for Family Research at URMC. “Inflammation underlies a number of health conditions which may all be connected, and that makes it a very compelling target for developmental health research starting in the prenatal period.”

Thomas O'Connor, Ph.D.

Past research seeking to explain how and why maternal psychological states and physiology may have a long-term impact on child health focused on stress physiology, and especially the stress hormone cortisol, as a likely explanation. But the implications for human health were only modest, underscoring the need for further research.

Clinical scientists have known for some time that proinflammatory cytokines can be measured in the blood at varying levels among individuals. If URMC researchers find that prenatal immune activation does alter child growth and development, then that would open up new targets for intervention.

“In addition to providing new basic knowledge, our study is also positioned to identify additional mechanisms that may guide clinical treatment and improve child health outcomes and ultimately population health,” said O’Connor, the study director.

The grant is part of $157 million in funding announced today by the National Institutes of Health as it launches its Environmental influences on Child Health Outcomes (ECHO) program. The ECHO program will investigate how exposure to a range of environmental factors in early development — from conception through early childhood — influences the health of children and adolescents.

Working with collaborators at the University of Pittsburgh Medical Center, researchers will follow 500 families from the first trimester of pregnancy through the child’s fourth birthday. Researchers will administer prenatal assessments to examine social and family factors, psychological symptoms such as depression and anxiety, and clinical measures such as diet and nutrition. Biological samples including blood, urine, and saliva will also be collected from the mothers in each trimester, and regularly from babies starting at birth.

At birth, cord blood and placenta samples will be collected through a process developed by co-investigator Richard K. Miller, Ph.D., Professor of Obstetrics and Gynecology, and colleagues at URMC. Then, throughout the first four years of life, the child will undergo behavioral and developmental assessments, brain imaging, and dual energy X-ray absorptiometry, a non-invasive scan that quantifies body composition. Children’s immune, endocrine, and metabolic system development will also be tracked from samples collected throughout the child’s first 4 years.

“Every baby should have the best opportunity to remain healthy and thrive throughout childhood,” said Francis S. Collins, M.D., Ph.D., National Institutes of Health Director. “ECHO will help us better understand the factors that contribute to optimal health in children.”

The study builds on previous URMC research and will involve a wide range of university specialists including experts from the Departments of Psychiatry, Neurology, Pediatrics, Obstetrics and Gynecology, and Biostatistics and Computational Biology. The study will capitalize on a range of medical research infrastructure already present at the university, including the Rochester Center for Brain Imaging, the Rochester Human Immunology Center, the UR Genomics Research Center, and the Ernest J. Del Monte Neuromedicine Institute.

In addition to O’Connor and Miller, the URMC team includes Sanjiv Amin, M.B.B.S., Richard Aslin, Ph.D., Emily Barrett, Ph.D., Mary Caserta, M.D., John Foxe, Ph.D., Philip Katzman, M.D., Jan Moynihan, Ph.D., Shawn Murphy, Ph.D., Eva Pressman, M.D., Kristin Scheible, M.D., Chris Stodgell, Ph.D., and Xin Tu, Ph.D. They are assisted by Carrie Salafia, M.D., of Placental Analytics, LLC. The team at the University of Pittsburgh and Magee’s Women’s Hospital is led by Hyagriv Simhan, M.D., with Pathik Wadhwa, M.D., Ph.D., and Claudia Buss Ph.D., of the University of California-Irvine; and Damien Fair, Ph.D., and Alice Graham, Ph.D., of Oregon Health and Science University.

Article Source

Neurology Celebrates 50 Years of Leadership in Research, Care, and Education

Wednesday, September 21, 2016


Department of Neurology faculty in 1966 and today

The University of Rochester Medical Center (URMC) Department of Neurology is honoring the 50th anniversary of its founding. The occasion will be marked with four day-long celebration of the department’s history, achievements, alumni, and vision for the future.

“The history of the department is ultimately a human story of relationships, inspiring leadership, and how a rare combination of great intellect, common sense, humility, wit, and charm can move the neurological needle on a global scale,” said Robert Holloway, M.D., M.P.H., the chair of the Department of Neurology. “From its humble beginnings 50 years ago, this department has shaped the careers of hundreds of caregivers and, through its care and research, impacted the lives of millions of patients.”

The URMC Department of Neurology was founded by Bob Joynt, M.D. in 1966 who served as its chair until 1986. The department has been subsequently led by Robert Griggs (1986-2008) Steve Goldman (2008-2012), and Holloway (2012-present).

Over the past five decades, the department has grown from its original six faculty members and is now comprised of more than 260 physicians, nurses, residents, fellows, and support staff. The department is among the top in the nation in research funding and has been a pioneer in experimental therapeutics, its clinical programs are regularly recognized among the best in the country, and its education and training programs are considered national models.

The celebration will take place September 22-24, 2016 and will include the Annual Goldberg Lecture, a gala banquet at the Monroe Golf Club, and a scientific session including posters and research updates by current faculty and alumni.

A Pioneer in Research

The Department of Neurology has consistently ranked among the top 10 in the nation in the amount of research funding it receives from NIH. Total funding for the department in 2015 exceeded $20 million.

The department’s basic research ranges from efforts to understand the fundamental biology of the central nervous system to identifying the mechanisms of neurological disorders. Much of the Neurology’s basic research activity is concentrated in the Center for Neural Development and Disease and the Center for Translational Neuromedicine, the latter operates labs in both Rochester and at the University of Copenhagen.

Neurology is also home to several leading centers that focus on muscular dystrophy research, including the Fields Center for FSHD & Neuromuscular Research, the Wellstone Muscular Dystrophy Cooperative Research Center , and the department maintains a national registry of patients with muscular dystrophy that is used by clinicians and scientists across the country to better understand the complex symptoms of the disease and recruit study participants.

The department is widely recognized as a pioneer in experimental therapies and clinical research. In the mid-1980’s, Joynt tapped Ira Shoulson, M.D., and Karl Kieburtz M.D., M.P.H., to create what would eventually be called the Clinical Trials Coordination Center, a unique academic-based enterprise with the scientific expertise and infrastructure necessary to work with the pharmaceutical and biotech industry, foundations, and the NIH to design and run multi-center clinical trials. Since its inception, the CTCC, which was renamed the Center for Human Experimental Therapeutics in 2012, has conducted 120 clinical trials and is responsible for bringing six FDA-approved drugs to market to treat Parkinson’s disease, Huntington’s disease, and periodic paralysis.

URMC neurologists have also been instrumental in organizing the international networks of clinicians and researchers necessary to carry out multi-center clinical trials. These efforts led to the creation of the Parkinson’s Study Group, the Huntington’s Study Group, and the Muscle Study Group. The department is also one of the inaugural members of the NIH-sponsored NeuroNEXT research network and has recently established a program in global neurology.

Excellence in Clinical Care

The URMC Department of Neurology’s clinical enterprise is one the largest and most sophisticated of its kind in the country and its expertise across the sub-specialties of neurological care attracts patients from across the globe. The department is currently ranked among the top programs in the nation by US News & World Report.

URMC is home to upstate New York’s largest, most advanced, and multi-disciplinary care programs for Parkinson’s disease and movement disorders, muscular dystrophy and neuromuscular disorders, multiple sclerosis, neuro-oncology, and epilepsy.

In recent years, the department has launched a neurohospitalist program, opened the region’s only NeuroMedicine Critical Care Unit, was designated a Comprehensive Stroke Center by the Joint Commission and the American Heart Association/American Stroke Association, and opened the URMC Headache Center.

URMC neurologists have also been pioneers in expanding access to specialized care via technologies such as telemedicine and mobile applications.

A National Model in Education

Rochester is a national magnet for medical students, resident, and fellows. Since 2001, eight percent of the graduates of the School of Medicine and Dentistry have matched into either adult or child neurology residency programs, compared to a national average of one percent. The department’s adult residency program is considered to be one of the top programs nationally and is highly sought after by medical graduates. This year the department received 574 applications for 6 adult residency positions.

The department’s NIH-sponsored training grant in Experimental Therapeutics is in its 26th year and is one of the longest continually-funded NIH training programs in the country. URMC neurologists have also helped develop and oversee neuromedicine education programs in Poland, China, Zambia, Malawi, and Spain.

Ralph Jozefowicz, M.D., who has overseen the department’s education programs for more than 20 years, has been honored by the Association of American Medical Colleges and the American Association of Neurology for enhancing the education of neurologists nationwide.

Alumni of department’s training programs have or are currently practicing neurology in more than 20 countries and 35 states and have gone on to hold various academic, government, and industry leadership positions.

“Over the next 50 years, the field of neurology will be profoundly transformed, from our concept of disease, to our ability to diagnose with more precision, to the impact of our therapies, to the way we teach our trainees,” said Holloway. “But some things will not change. The patient will remain at the center of all we do, guiding our way and reminding us that the most important things we do with our lives we do for others.”

Article Source